Innocan Pharma Corporation

Innocan's VALITIC Skincare Brand to Attend Shoptalk Fall 2026

Nashville – September 29, 2026 -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) will showcase its VALITIC skincare brand at Shoptalk Fall 2026, a retail industry event running September 29 through October 1 at Music City Center in Nashville, Tennessee.

Shoptalk Fall draws more than 3,500 retail executives to Nashville

The 2026 edition brings together over 3,500 industry leaders, including 1,300-plus retailer and consumer brand executives, under the theme "Retail Unplugged." Sessions center on strategies, technologies and consumer trends shaping the retail sector heading into 2027, spanning verticals from beauty and apparel to electronics and automotive.

Innocan Pharma Q2 Revenue Falls 25% to $5.25M on US Tariff Uncertainty

Herzliya, Israel – September 04, 2026 -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) reported second-quarter fiscal 2026 revenue of US$5.25 million (CAD 7.3 million), a 25.06% decline from US$7.01 million in the same period last year, as shifting U.S. customs and tariff policy under the Trump administration disrupted sales.

Gross margin holds above 90% despite revenue drop

Gross profit fell 23.0% to US$4.769 million, but gross margin remained elevated at 90.8% for the three months ended June 30, 2026, up from 88.4% a year earlier. The company attributed the resilience to its direct-to-consumer model and disciplined cost structure at consumer wellness subsidiary B.I. Sky Global Ltd., which it owns 60%.

Subscribe to Innocan Pharma Corporation